STAKEHOLDERS’ ANALYSIS TOOLS TO SUPPORT THE OPEN INNOVATION PROCESS MANAGEMENT – CASE STUDY
暂无分享,去创建一个
Marcelo Nogueira Cortimiglia | Istefani Carísio de Paula | Samanta Yang | André Korzenowski | M. Cortimiglia | I. C. Paula | A. Korzenowski | Samanta Yang
[1] Basil Achilladelis,et al. The dynamics of technological innovation : the case of the pharmaceutical industry , 2001 .
[2] N. Sakkab,et al. Connect and Develop : Inside Procter & Gamble's New Model for Innovation , 2006 .
[3] Esther F. Schmid,et al. Is pharmaceutical R&D just a game of chance or can strategy make a difference? , 2004, Drug discovery today.
[4] N. Sakkab,et al. Implementing Open Innovation , 2007 .
[5] Jan Terje Karlsen,et al. Project Stakeholder Management , 2002 .
[6] John Dixon,et al. Vertical disintegration: a strategy for pharmaceutical businesses in 2009? , 2009, Nature Reviews Drug Discovery.
[7] M. Kendall. Elementary Statistics , 1945, Nature.
[8] Mark J. Belsey,et al. Drug developer strategies to boost competitiveness , 2007, Nature Reviews Drug Discovery.
[9] H. Chesbrough. The Era of Open Innovation , 2003 .
[10] C. Tralau-Stewart,et al. Drug discovery: new models for industry-academic partnerships. , 2009, Drug discovery today.
[11] Janet M. Dewdney,et al. Putting a new spin on R&D assets in the pharmaceutical industry , 1998 .
[12] Timothy W. Nix,et al. Strategies for assessing and managing organizational stakeholders , 1991 .
[13] S. Mazzocchi. Open Innovation: The New Imperative For Creating and Profiting From Technology , 2004 .
[14] M. Dodgson,et al. The Role of Technology in the Shift Towards Open Innovation: The Case of Procter & Gamble , 2006 .
[15] N. Cohen,et al. Open innovation networks between academia and industry: an imperative for breakthrough therapies , 2009, Nature Medicine.
[16] B. Dousset. Innovation and network structural dynamics: Study of the alliance network of a major sector of the biotechnology industry , 2005 .
[17] Henry Chesbrough,et al. Open Innovation: The New Imperative for Creating and Profiting from Technology , 2003 .
[18] G. Hayward. Managing Innovation: Integrating Technological, Market and Organizational Change , 1998 .
[19] Paul G. Hoel,et al. Elementary statistics , 1971 .
[20] R. Freeman. Strategic Management: A Stakeholder Approach , 2010 .
[21] Ian Sommerville,et al. Requirements Engineering: Processes and Techniques , 1998 .
[22] Ronald K. Mitchell,et al. Toward a Theory of Stakeholder Identification and Salience: Defining the Principle of who and What Really Counts , 1997 .
[23] Jing Zhang,et al. Technological Knowledge Base, R&D Organization Structure and Alliance Formation: Evidence from the Biopharmaceutical Industry , 2007 .
[24] R. Rothwell. Towards the Fifth‐generation Innovation Process , 1994 .
[25] Shabbir T. Anik. Drug development: A new map for creating sustainable competitive advantages , 2002 .